(IPAR) Inter Parfums - Ratings and Ratios
Fragrances, Sprays, Deodorants, Body Care
IPAR EPS (Earnings per Share)
IPAR Revenue
Description: IPAR Inter Parfums
Inter Parfums Inc (NASDAQ:IPAR) is a global player in the fragrance and personal care industry, operating through two main segments: European and US-based operations. The company has a diverse portfolio of licensed and proprietary brands, including luxury fashion houses like Boucheron, Jimmy Choo, and Karl Lagerfeld, as well as more accessible brands like Guess and Abercrombie & Fitch.
The companys business model is built around designing, manufacturing, and distributing fragrances and related products to a wide range of customers, including department stores, specialty retailers, and e-commerce platforms. With a strong presence in both the US and international markets, Inter Parfums has established itself as a significant player in the global personal care products industry.
To evaluate the companys performance, key metrics to consider include revenue growth, gross margin, and operating profit margin. With a market capitalization of over $4.2 billion, Inter Parfums has demonstrated a strong ability to generate cash and invest in its business. The companys return on equity (RoE) of 31.02% suggests a high level of profitability, while its price-to-earnings (P/E) ratio of 25.79 indicates a moderate valuation relative to its earnings. Other key performance indicators (KPIs) to monitor include sales growth, brand diversification, and distribution channel expansion.
From a quantitative perspective, additional KPIs to consider when evaluating Inter Parfums include its dividend yield, payout ratio, and cash conversion cycle. The companys ability to maintain a stable dividend payout and manage its working capital effectively can provide insights into its financial health and operational efficiency. Furthermore, metrics such as brand concentration, product innovation, and marketing spend can help investors understand the companys competitive positioning and growth prospects.
IPAR Stock Overview
| Market Cap in USD | 3,623m |
| Sub-Industry | Personal Care Products |
| IPO / Inception | 1988-01-15 |
IPAR Stock Ratings
| Growth Rating | 50.0% |
| Fundamental | 79.7% |
| Dividend Rating | 81.6% |
| Return 12m vs S&P 500 | -18.6% |
| Analyst Rating | 4.50 of 5 |
IPAR Dividends
| Dividend Yield 12m | 3.22% |
| Yield on Cost 5y | 9.58% |
| Annual Growth 5y | 55.50% |
| Payout Consistency | 94.1% |
| Payout Ratio | 61.9% |
IPAR Growth Ratios
| Growth Correlation 3m | -90.1% |
| Growth Correlation 12m | 2.6% |
| Growth Correlation 5y | 81.6% |
| CAGR 5y | 23.54% |
| CAGR/Max DD 5y | 0.61 |
| Sharpe Ratio 12m | 0.52 |
| Alpha | -18.40 |
| Beta | 0.811 |
| Volatility | 34.39% |
| Current Volume | 207.2k |
| Average Volume 20d | 221.1k |
| Stop Loss | 112.6 (-3.4%) |
| Signal | 0.58 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (230.0m TTM) > 0 and > 6% of Revenue (6% = 87.5m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA 10.27pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 44.83% (prev 38.52%; Δ 6.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 218.6m <= Net Income 230.0m (YES >=105%, WARN >=100%) |
| Net Debt (128.1m) to EBITDA (291.1m) ratio: 0.44 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (32.1m) change vs 12m ago -0.36% (target <= -2.0% for YES) |
| Gross Margin 64.52% (prev 63.90%; Δ 0.62pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 99.73% (prev 99.92%; Δ -0.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 36.75 (EBITDA TTM 291.1m / Interest Expense TTM 7.41m) >= 6 (WARN >= 3) |
Altman Z'' 7.27
| (A) 0.42 = (Total Current Assets 987.0m - Total Current Liabilities 333.0m) / Total Assets 1.56b |
| (B) 0.50 = Retained Earnings (Balance) 787.0m / Total Assets 1.56b |
| (C) 0.19 = EBIT TTM 272.3m / Avg Total Assets 1.46b |
| (D) 1.56 = Book Value of Equity 785.5m / Total Liabilities 505.0m |
| Total Rating: 7.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.67
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 4.98% = 2.49 |
| 3. FCF Margin 12.56% = 3.14 |
| 4. Debt/Equity 0.31 = 2.45 |
| 5. Debt/Ebitda 0.90 = 1.91 |
| 6. ROIC - WACC 12.64% = 12.50 |
| 7. RoE 29.20% = 2.43 |
| 8. Rev. Trend 60.99% = 3.05 |
| 9. Rev. CAGR 6.55% = 0.82 |
| 10. EPS Trend 21.07% = 0.53 |
| 11. EPS CAGR -9.16% = -1.14 |
What is the price of IPAR shares?
Over the past week, the price has changed by +4.35%, over one month by -6.84%, over three months by -12.07% and over the past year by -4.17%.
Is Inter Parfums a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IPAR is around 117.94 USD . This means that IPAR is currently overvalued and has a potential downside of 1.21%.
Is IPAR a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IPAR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 163.3 | 40.2% |
| Analysts Target Price | 159.5 | 36.9% |
| ValueRay Target Price | 131.4 | 12.8% |
Last update: 2025-08-19 02:48
IPAR Fundamental Data Overview
CCE Cash And Equivalents = 205.4m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 22.4701
P/E Forward = 22.2717
P/S = 2.4833
P/B = 4.3162
P/EG = 2.73
Beta = 1.449
Revenue TTM = 1.46b USD
EBIT TTM = 272.3m USD
EBITDA TTM = 291.1m USD
Long Term Debt = 153.1m USD (from longTermDebt, last quarter)
Short Term Debt = 107.5m USD (from shortTermDebt, last quarter)
Debt = 260.6m USD (Calculated: Short Term 107.5m + Long Term 153.1m)
Net Debt = 128.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.68b USD (3.62b + Debt 260.6m - CCE 205.4m)
Interest Coverage Ratio = 36.75 (Ebit TTM 272.3m / Interest Expense TTM 7.41m)
FCF Yield = 4.98% (FCF TTM 183.2m / Enterprise Value 3.68b)
FCF Margin = 12.56% (FCF TTM 183.2m / Revenue TTM 1.46b)
Net Margin = 15.77% (Net Income TTM 230.0m / Revenue TTM 1.46b)
Gross Margin = 64.52% ((Revenue TTM 1.46b - Cost of Revenue TTM 517.6m) / Revenue TTM)
Tobins Q-Ratio = 4.68 (Enterprise Value 3.68b / Book Value Of Equity 785.5m)
Interest Expense / Debt = 0.69% (Interest Expense 1.79m / Debt 260.6m)
Taxrate = 24.20% (from yearly Income Tax Expense: 65.0m / 268.4m)
NOPAT = 206.4m (EBIT 272.3m * (1 - 24.20%))
Current Ratio = 2.96 (Total Current Assets 987.0m / Total Current Liabilities 333.0m)
Debt / Equity = 0.31 (Debt 260.6m / last Quarter total Stockholder Equity 839.4m)
Debt / EBITDA = 0.90 (Net Debt 128.1m / EBITDA 291.1m)
Debt / FCF = 1.42 (Debt 260.6m / FCF TTM 183.2m)
Total Stockholder Equity = 787.8m (last 4 quarters mean)
RoA = 14.73% (Net Income 230.0m, Total Assets 1.56b )
RoE = 29.20% (Net Income TTM 230.0m / Total Stockholder Equity 787.8m)
RoCE = 28.94% (Ebit 272.3m / (Equity 787.8m + L.T.Debt 153.1m))
RoIC = 21.07% (NOPAT 206.4m / Invested Capital 979.5m)
WACC = 8.43% (E(3.62b)/V(3.88b) * Re(9.0%)) + (D(260.6m)/V(3.88b) * Rd(0.69%) * (1-Tc(0.24)))
Shares Correlation 5-Years: 100.0 | Cagr: 0.30%
Discount Rate = 9.0% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 66.25% ; FCFE base≈117.9m ; Y1≈77.4m ; Y5≈35.4m
Fair Price DCF = 18.56 (DCF Value 596.0m / Shares Outstanding 32.1m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 60.99 | Revenue CAGR: 6.55%
Rev Growth-of-Growth: -9.08
EPS Correlation: 21.07 | EPS CAGR: -9.16%
EPS Growth-of-Growth: 29.78
Additional Sources for IPAR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle